Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GE

WKN: A1T7HJ | ISIN: US37427X1046 | Ticker: GTN0
Siehe auch GETINGE AB
Frankfurt
20.11.26 | 08:23
24,000 Euro
-1,64 % -0,400
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
GETINGE AB ADR Chart 1 Jahr
5-Tage-Chart
GETINGE AB ADR 5-Tage-Chart
RealtimeGeldBriefZeit
24,00025,40016:59

Aktuelle News zur GETINGE AB ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Getinge US Service Receives NBRI Circle of Excellence Award for Seventh Consecutive Year7
GETINGE AB ADR Aktie jetzt für 0€ handeln
12.11.Getinge establishes Sustainable Financing Framework1
09.11.Getinge taps Philips image-guided therapy leader for acute care division1
09.11.Getinge AB: Getinge appoints Stacy Beske as President Acute Care Therapies248Press release Gothenburg, Sweden, on November 9, 2026 Getinge has appointed Stacy Beske as President Acute Care Therapies and member of the Executive Team, reporting to Mattias Perjos, President...
► Artikel lesen
26.10.Getinge's acute care president named CEO of Vitrolife9
26.10.Getinge AB: Getinge announces departure of Elin Frostehav as President Acute Care Therapies211Press release Gothenburg, Sweden, on October 26, 2026 Getinge today announced that Elin Frostehav will leave her position as President Acute Care Therapies and member of the Executive Team to accept...
► Artikel lesen
21.10.Getinge AB (publ) reports Q3 results3
21.10.Getinge steigert Marge und Cashflow im dritten Quartal 2026 - Jahresprognose bestätigt3
21.10.Getinge Q3 2026 slides: margins expand toward mid-term target range3
21.10.Getinge AB Q3 Profit Advances2
21.10.Getinge AB: Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction210Press release Gothenburg, Sweden on October 21, 2026 "We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong...
► Artikel lesen
15.10.Nomination Committee appointed ahead of Getinge's Annual General Meeting 20271
13.10.Getinge brings its smallest Edi catheter to the U.S. market following FDA clearance2
07.10.Getinge Life Science president is leaving14
07.10.Getinge AB: Getinge announces departure of Eric Honroth, President Life Science341Press release Gothenburg, Sweden, on October 7, 2026 Getinge today announced that Eric Honroth will resign as President Life Science and member of the Executive Team to accept an external opportunity....
► Artikel lesen
07.10.Getinge invites fund managers, analysts, and media to Q3 Report 2026 conference call2
25.09.GETINGE: Insights from a fast-growing market1
15.09.Getinge auf der Morgan Stanley Gesundheitskonferenz: Turnaround macht Fortschritte4
08.09.Getinge takes AI-powered surgical planning further with Torin Plan Optimizer5
02.09.Getinge and Beredskapslyftet strengthen life-saving care in Ukraine through targeted ECMO support2
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1